Telix Pharmaceuticals | TLX - Despesas Operacionais

Preço das Ações
12.73
Mudança Diária
0.23 1.84%
Mensal
24.80%
Anual
-56.43%
Q1 Previsão
12.48




Despesas Operacionais Alterar Data
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesoblast USD 82.31M 26.16M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Pacific Edge NZD 25.34M 2.03M 2025-12
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
Polynovo AUD 68.22M 1.24M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 922.51M 49.28M 2025-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12